Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin
1Department of Thoracic Surgery, Chinese PLA General Hospital, Beijing, China. cp661943@yeah.net.
Objective:
Accumulating evidence suggests that SPARC/osteonectin, cwcv, and kazal-like domain proteoglycan 1 (SPOCK1) contributes to the initiation and progression of human cancers. However, little is known about the function mechanisms of SPOCK1 in non-small cell lung cancer (NSCLC). The aim of this study was to investigate the molecular mechanism of SPOCK1 in NSCLC.
Patients And Methods:
The expression levels of SPOCK1 in NSCLC tissues and cell lines were analyzed by qRT-PCR and Western blotting. The proliferative activity of NSCLC cells was determined by MTT and colony formation assays. The transwell assay was used to examine the cell migration and invasive ability. To study the impact of SPOCK1 on Wnt/β‑catenin signaling, we further performed Western blotting for related proteins in this pathway.
Results:
We observed that the expression of SPOCK1 at both protein and mRNA levels was also increased in human NSCLC tissues and cell lines. Functionally, down-regulation of SPOCK1 in NSCLC cells markedly suppressed cell proliferation, colony formation, migration and invasion in vitro. Mechanistically, we found that indicated the activation of Wnt/β-catenin pathway was suppressed by SPOCK1 silencing.
Conclusions:
The expression of SPOCK1 served as a tumor promoter, possibly through the Wnt/β-catenin signaling pathway in NSCLC. Targeting SPOCK1 could be a potential therapeutic strategy in NSCLC.
Insights
SPOCK1 promotes non-small cell lung cancer (NSCLC) by activating the Wnt/β-catenin pathway. Inhibiting SPOCK1 may offer a new therapeutic approach for NSCLC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- SPOCK1 (SPARC/osteonectin, cwcv, and kazal-like domain proteoglycan 1) is implicated in human cancer initiation and progression.
- The specific role and molecular mechanisms of SPOCK1 in non-small cell lung cancer (NSCLC) remain largely unelucidated.
Purpose of the Study:
- To investigate the functional mechanisms of SPOCK1 in non-small cell lung cancer (NSCLC).
- To explore the potential of targeting SPOCK1 as a therapeutic strategy for NSCLC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blotting to assess SPOCK1 expression in NSCLC tissues and cell lines.
- MTT and colony formation assays to evaluate cell proliferation.
- Transwell assays to determine cell migration and invasion.
- Western blotting to analyze Wnt/β-catenin signaling pathway components.
Main Results:
- SPOCK1 expression was significantly elevated at both mRNA and protein levels in NSCLC tissues and cell lines.
- Down-regulation of SPOCK1 suppressed NSCLC cell proliferation, colony formation, migration, and invasion in vitro.
- SPOCK1 silencing led to the suppression of the Wnt/β-catenin signaling pathway.
Conclusions:
- SPOCK1 acts as a tumor promoter in NSCLC, potentially via the Wnt/β-catenin signaling pathway.
- Targeting SPOCK1 presents a promising therapeutic avenue for NSCLC treatment.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Specific Gene Expression
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
What is Cell Signaling?
Cell Migration

